Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
Jason Sperry
Study ID
NCT07212998
Phase
PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Burn Injury
  • Thermal Burn

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Plasma — BIOLOGICAL
    urgent release early plasma resuscitation following burn/thermal injury
  • Standard care — BIOLOGICAL
    Standard resuscitation as dictated by institutional protocol

Study Details

The Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) trial will be a 6-year (4-year enrollment), open label, phase-3, multi-center, early in-hospital phase randomized trial utilizing burn centers from within the LITES network and will enroll approximately 750 injured adult patients who have suffered large 2nd or 3rd degree thermal burns on at least 20% of their body surface requiring burn resusciation. The objective is to determine if initiating plasma resuscitation as soon as possible upon arrival to an emergency department or burn unit is the most effective resuscitation for those who have experienced large thermal burns and significantly reduces the morbidity and mortality attributable to post-injury complications as compared to standard in-hospital resuscitation practice.

Key Dates

Start date
Jun 30, 2026
Status verified
May 2026
Primary completion
Apr 30, 2030
Completion
May 31, 2030

Study Design

Enrollment
750 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Early Plasma Resuscitation
    Subjects will receive early plasma resuscitation initiated in the emergency department/burn resuscitation area over an approximate 4-hour period from the time of randomization, stratified by Total Body Surface Area (TBSA)%.
  • Active Comparator: Standard Care
    Subjects will receive resuscitation following individual site standard burn resuscitation practice.

Primary Outcome Measure

28-day Mortality or Persistent Organ Dysfunction [ Time Frame: 28 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of PittsburghPittsburghPennsylvania15213
Jason Sperry, MD
[email protected]
412-647-3065

Find similar trials in Pittsburgh, PA

By research site
University of Pittsburgh· Pittsburgh, PA

Related Studies